Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Chronic inflammation causing multiple myeloma? I understand the two studies linked below are a stretch. Or at least my linking the two as my reasoning for possible causes of multiple myeloma. But hear me out.
Want to know the amazing thing about the first study linked below? While chronic disease accounts for more than 20% of cancers, a few simple lifestyle therapies can dramatically reduce the occurance of these cancers.
I purposely linked the subhead above to highlight the importance of “chronic inflammation.” If you have pain in your back or your knees, you know what I’m talking about. Frequent moderate exercise, better nutrition such as fruit and veggie intake, and even supplementation such as omega-3 fatty acids or curcumin all reduce a person’s chronic inflammation. And if you reduce your chronic inflammation, you will reduce your risk of cancer.
When I say “frequent, moderate exercise” I’m talking about going for a brisk walk everyday. I’m not talking about running marathons. And when I talk about better nutrition, I’m only advising that you add a fruit or a veggie at each meal. And nutritional supplementation is the easiest therapy of all. Simply add a capsule at the end of your meal.
The bottom line, for me anyway, is my experience of remaining in complete remission from my diagnosis of MM in early 1994 through anti-inflammatory diet, anti-inflammatory supplementation and an anti-inflammatory lifestyle.
If you would like to learn more about anything I’ve discussed above, scroll down the page, write a question or a comment below and I will reply to you ASAP.
Hang in there,
“Eight common chronic diseases accounted for more than one-fifth of incident cancer risk, according to prospective study results.
These conditions increase cancer risk at a rate comparable to five major lifestyle factors, such as smoking and lack of physical activity.
Xifeng Wu, MD, PhD — professor, Betty B. Marcus chair in cancer prevention, and director of Center for Translational and Public Health Genomics at The University of Texas MD Anderson Cancer Center — along with Huakang Tu, PhD, postdoctoral fellow in epidemiology at MD Anderson, and colleagues conducted a prospective cohort study that included 405,878 participants in Taiwan.
Investigators assessed eight chronic diseases or markers: blood pressure, total cholesterol, heart rate, diabetes, proteinuria, glomerular filtration rate, pulmonary disease and gouty arthritis marker.
Average follow-up was 8.7 years.
All diseases and markers appeared significantly associated with cancer mortality, and all of them except for blood pressure and pulmonary disease appeared significantly associated with cancer incidence.
Results also showed physical activity reduced cancer incidence by nearly 50% and cancer mortality by more than one-quarter.
HemOnc Today spoke with Wu about the study, why chronic disease often is an overlooked risk factor for cancer, and the implications of these findings.
Question: How did you choose the chronic diseases to study?
Answer: We selected five common chronic diseases for evaluation based on their disease burden worldwide. Cancer — together with cardiovascular disease, diabetes, chronic kidney disease and respiratory disease — account for 83% of all chronic disease deaths. Additionally, other less fatal but common chronic diseases are among the leading causes of disability that severely affects quality of life. For example, 22.7% U.S. adults reported having doctor-diagnosed arthritis between 2010 and 2012, and 9.8% reported arthritis-attributable activity limitation. Gouty arthritis is the most common inflammatory arthritis worldwide.
Q: The finding that chronic disease is as much a risk factor as other key lifestyle factors is particularly striking. Can you expand on this?
A: In our study, we found the total contribution to cancer incidence from the eight chronic diseases or markers — a population-attributable fraction of 20.5% — was close to that of five major lifestyle factors. These factors — ever smoking, insufficient physical activity, insufficient fruit and vegetable intake, ever alcohol consumption, and nonideal BMI — account for a population-attributable fraction of 24.8%. The total contribution to cancer mortality from the eight chronic diseases or markers (population-attributable fraction, 38.9%) was also close to that of the five major lifestyle factors (population-attributable fraction, 39.7%).
Q: Why are chronic diseases not targeted in cancer prevention strategies?
A: Even though some previous studies have showed certain chronic diseases — such as diabetes — may predispose to cancer, cancer prevention strategies do not target chronic diseases, and this probably is because of the modest associations observed. Previous studies generally assessed chronic diseases or disease markers individually. As chronic diseases are typically clustered, it is necessary to study them simultaneously to elucidate their joint impact on cancer risk, but few data are available on this topic. Our study showed that the joint impact of common chronic disease and markers on cancer is substantial.
Q: Can you offer insights into the mechanisms that may explain why chronic disease can lead to cancer incidence ?
A: A common link between various chronic diseases and cancer could be chronic inflammation. In addition, different chronic diseases or markers may lead to cancer incidence through different mechanisms. For example, diabetes may increase cancer by several mechanisms, including hyperinsulinemia, hyperglycemia or chronic inflammation.
“Multiple myeloma (MM) and its pre-cancerous stage monoclonal gammopathy of undetermined significance (MGUS) allow to study immune responses and the chronology of inflammation in the context of blood malignancies. Both diseases are characterized by the production of a monoclonal immunoglobulin (mc Ig) which for subsets of MGUS and MM patients targets pathogens known to cause latent infection, a major cause of inflammation. Inflammation may influence the structure of both polyclonal (pc) Ig and mc Ig produced by malignant plasma cells via the sialylation of Ig Fc fragment…
… Thus in MGUS as in MM, hyposialylation of mc IgGs is concomitant with increased levels of cytokines that play a major role in inflammation and anti-microbial response, which implies that infection, inflammation, and abnormal immune response contribute to the pathogenesis of MGUS and MM…”